Format
Sort by
Items per page

Send to

Choose Destination

Best matches for KETOCONAZOLE/TU:

Liver injury associated with ketoconazole: review of the published evidence. Greenblatt HK et al. J Clin Pharmacol. (2014)

Can pityriasis versicolor be treated with 2% ketoconazole foam? Cantrell WC et al. J Drugs Dermatol. (2014)

Baboon syndrome induced by ketoconazole. Gulec AI et al. Cutan Ocul Toxicol. (2014)

Search results

Items: 1 to 20 of 3014

1.

Hepatic safety of ketoconazole in Cushing's syndrome: results of a Compassionate Use Programme in France.

Young J, Bertherat J, Vantyghem MC, Chabre O, Senoussi S, Chadarevian R, Castinetti F; Compassionalte use Programme.

Eur J Endocrinol. 2018 May;178(5):447-458. doi: 10.1530/EJE-17-0886. Epub 2018 Feb 22.

PMID:
29472378
2.

Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN.

Valassi E, Franz H, Brue T, Feelders RA, Netea-Maier R, Tsagarakis S, Webb SM, Yaneva M, Reincke M, Droste M, Komerdus I, Maiter D, Kastelan D, Chanson P, Pfeifer M, Strasburger CJ, Tóth M, Chabre O, Krsek M, Fajardo C, Bolanowski M, Santos A, Trainer PJ, Wass JAH, Tabarin A; ERCUSYN Study Group.

Eur J Endocrinol. 2018 Apr;178(4):399-409. doi: 10.1530/EJE-17-0997. Epub 2018 Feb 12.

PMID:
29440375
3.

Long-term pubic dermatitis diagnosed as white piedra.

Landero J.

Cutis. 2017 Dec;100(6):448-450.

PMID:
29360892
4.

Dapaconazole versus ketoconazole in the treatment of interdigital tinea pedis.

Gobbato AAM, Gobbato CARS, Moreno RA, Antunes NJ, De Nucci G.

Int J Clin Pharmacol Ther. 2018 Jan;56(1):31-33. doi: 10.5414/CP203124. No abstract available.

PMID:
29191265
5.

Effects of ketoconazole on cyclophosphamide metabolism: evaluation of CYP3A4 inhibition effect using the in vitro and in vivo models.

Yang L, Yan C, Zhang F, Jiang B, Gao S, Liang Y, Huang L, Chen W.

Exp Anim. 2018 Feb 9;67(1):71-82. doi: 10.1538/expanim.17-0048. Epub 2017 Nov 13.

6.

Formulation and evaluation of selected transmucosal dosage forms containing a double fixed-dose of acyclovir and ketoconazole.

Viljoen JM, Botes D, Steenekamp JH.

Eur J Pharm Sci. 2018 Jan 1;111:503-513. doi: 10.1016/j.ejps.2017.10.033. Epub 2017 Nov 5.

PMID:
29080856
7.

Germ Cell Neoplasia in Situ and Preserved Fertility Despite Suppressed Gonadotropins in a Patient With Testotoxicosis.

Juel Mortensen L, Blomberg Jensen M, Christiansen P, Rønholt AM, Jørgensen A, Frederiksen H, Nielsen JE, Loya AC, Grønkær Toft B, Skakkebæk NE, Rajpert-De Meyts E, Juul A.

J Clin Endocrinol Metab. 2017 Dec 1;102(12):4411-4416. doi: 10.1210/jc.2017-01761.

PMID:
29029242
8.

Effects of Ketoconazole on the Pharmacokinetics of Mifepristone, a Competitive Glucocorticoid Receptor Antagonist, in Healthy Men.

Nguyen D, Mizne S.

Adv Ther. 2017 Oct;34(10):2371-2385. doi: 10.1007/s12325-017-0621-9. Epub 2017 Oct 11.

9.

Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis.

Galvão EL, Rabello A, Cota GF.

PLoS One. 2017 Oct 9;12(10):e0186117. doi: 10.1371/journal.pone.0186117. eCollection 2017. Review.

10.

Comparison of Oral Voriconazole Versus Oral Ketoconazole as an Adjunct to Topical Natamycin in Severe Fungal Keratitis: A Randomized Controlled Trial.

Sharma N, Singhal D, Maharana PK, Sinha R, Agarwal T, Upadhyay AD, Velpandian T, Satpathy G, Titiyal JS.

Cornea. 2017 Dec;36(12):1521-1527. doi: 10.1097/ICO.0000000000001365.

PMID:
28902012
11.

Putative contact ketoconazole shampoo-triggered pemphigus foliaceus in a dog.

Sung HJ, Yoon IH, Kim JH.

Can Vet J. 2017 Sep;58(9):914-918.

12.

Interaction of erythromycin and ketoconazole on the neurological, biochemical and behavioral responses in crucian carp.

Liu J, Cai Y, Lu G, Dan X, Wu D, Yan Z.

Environ Toxicol Pharmacol. 2017 Oct;55:14-19. doi: 10.1016/j.etap.2017.08.002. Epub 2017 Aug 7.

PMID:
28802958
13.

Tinea Capitis by Microsporum audouinii: Case Reports and Review of Published Global Literature 2000-2016.

Brito-Santos F, Figueiredo-Carvalho MHG, Coelho RA, Sales A, Almeida-Paes R.

Mycopathologia. 2017 Dec;182(11-12):1053-1060. doi: 10.1007/s11046-017-0181-1. Epub 2017 Jul 24. Review.

PMID:
28736794
14.

Study of Rheology and Polymer Adsorption Onto Drug Nanoparticles in Pharmaceutical Suspensions Produced by Nanomilling.

Negrini R, Aleandri S, Kuentz M.

J Pharm Sci. 2017 Nov;106(11):3395-3401. doi: 10.1016/j.xphs.2017.07.006. Epub 2017 Jul 18.

PMID:
28732711
15.

Mechanism-based risk assessment strategy for drug-induced cholestasis using the transcriptional benchmark dose derived by toxicogenomics.

Kawamoto T, Ito Y, Morita O, Honda H.

J Toxicol Sci. 2017;42(4):427-436. doi: 10.2131/jts.42.427.

16.

A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome.

Valassi E, Aulinas A, Glad CA, Johannsson G, Ragnarsson O, Webb SM.

Clin Endocrinol (Oxf). 2017 Nov;87(5):433-439. doi: 10.1111/cen.13414. Epub 2017 Jul 31.

PMID:
28665508
17.

In vitro additive interaction between ketoconazole and antimony against intramacrophage Leishmania (Leishmania) amazonensis amastigotes.

Nunes DCO, Bispo-da-Silva LB, Napolitano DR, Costa MS, Figueira MMNR, Rodrigues RS, Rodrigues VM, Yoneyama KAG.

PLoS One. 2017 Jun 29;12(6):e0180530. doi: 10.1371/journal.pone.0180530. eCollection 2017.

18.

Effects of (1E,4E)-2-Methyl-1,5-bis(4-nitrophenyl)penta-1,4-dien-3-one on Trypanosoma cruzi and Its Combinational Effect with Benznidazole, Ketoconazole, or Fluconazole.

Peron F, Lazarin-Bidóia D, Ud Din Z, Rodrigues-Filho E, Ueda-Nakamura T, Silva SO, Nakamura CV.

Biomed Res Int. 2017;2017:7254193. doi: 10.1155/2017/7254193. Epub 2017 May 23.

19.

BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY.

Geer EB, Shafiq I, Gordon MB, Bonert V, Ayala A, Swerdloff RS, Katznelson L, Lalazar Y, Manuylova E, Pulaski-Liebert KJ, Carmichael JD, Hannoush Z, Surampudi V, Broder MS, Cherepanov D, Eagan M, Lee J, Said Q, Neary MP, Biller BMK.

Endocr Pract. 2017 Aug;23(8):962-970. doi: 10.4158/EP171787.OR. Epub 2017 Jun 14.

PMID:
28614003
20.

[Pityriasis versicolor in infants: unusual clinical presentation and role of corticosteroids used as depigmenting agent for cosmetic purposes in the mother].

Dioussé P, Ly F, Bammo M, Lizia S, Diallo TAA, Dione H, Sarr F, Gueye RD, Gueye AM, Dieng MT, Diop BM, Ka MM.

Pan Afr Med J. 2017 Jan 23;26:31. doi: 10.11604/pamj.2017.26.31.11504. eCollection 2017. French.

Supplemental Content

Loading ...
Support Center